Redmond Asset Management, LLC Aptorum Group LTD Transaction History

Redmond Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.14 - $12.9 $123 - $1,393	-108 Reduced 0.17%	62,682 $72,000
Q1 2022 May 03, 2022	BUY	$1.22 - $2.28 $2,607 - $4,872	2,137 Added 3.52%	62,790 $105,000
Q4 2021 Feb 04, 2022	BUY	$1.5 - $2.64 $1,596 - $2,808	1,064 Added 1.79%	60,653 $91,000
Q3 2021 Oct 22, 2021	BUY	$2.39 - $3.22 $836 - $1,127	350 Added 0.59%	59,589 $153,000
Q1 2021 May 06, 2021	BUY	$2.45 - $4.17 $145,135 - $247,026	59,239 New	59,239 $176,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $8.62M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.